🕐 Browse by Era
📅 Political Timeline
Key political events in psychedelic history
LSD Made Illegal in California
California becomes the first state to criminalize LSD possession, setting the stage for federal action.
Controlled Substances Act
Nixon signs the CSA, placing psychedelics in Schedule I—highest restriction, no accepted medical use.
UN Convention on Psychotropic Substances
International treaty requiring countries to prohibit psychedelics, spreading prohibition globally.
FDA Approves DMT Research
Dr. Rick Strassman receives FDA approval for DMT studies—first psychedelic research in decades.
Johns Hopkins Psilocybin Research
Roland Griffiths begins landmark psilocybin studies, publishing groundbreaking results in 2006.
Denver Decriminalization
Denver becomes first US city to decriminalize psilocybin mushrooms via citizen ballot initiative.
Oregon Measure 109
Oregon voters approve Measure 109, legalizing psilocybin therapy services—first state to do so.
FDA Breakthrough Therapy
Multiple psychedelics receive FDA Breakthrough Therapy designation, accelerating clinical trials.
📜 Key Legislation
Major laws that shaped psychedelic policy
The cornerstone of US drug policy, creating the scheduling system that classifies drugs by medical use and abuse potential.
Impact
- 🔴 Placed psychedelics in Schedule I
- 🔴 Halted nearly all research
- 🔴 Created criminal penalties
First US state law to legalize psilocybin-assisted therapy under a regulated framework with trained facilitators.
Impact
- 🟢 Legal therapy framework
- 🟢 Licensed service centers
- 🟢 Model for other states
FDA designation expediting development and review of drugs showing substantial improvement over existing treatments.
Impact
- 🔵 Faster clinical trials
- 🔵 FDA collaboration
- 🔵 Path to approval
Second US state to legalize psilocybin therapy and decriminalize personal use of several psychedelics for adults.
Impact
- 🟢 Personal possession decriminalized
- 🟢 Healing centers by 2025
- 🟢 Multiple substances included
🗺️ Current Policy Landscape
Understanding today's regulatory environment
🏛️ Federal Level
Psychedelics remain Schedule I federally, but FDA is actively reviewing therapeutic applications.
Shifting🏠 State Level
Growing number of states considering or passing reform legislation, especially for therapy.
Reforming🏙️ Local Level
Multiple cities have decriminalized psilocybin and other plant medicines.
Active🌍 International
Several countries exploring therapeutic frameworks; some maintain traditional use exemptions.
Varied🌍 Global Policy Overview
How different countries approach psychedelic regulation
Netherlands
Truffles LegalPsilocybin truffles sold legally in smart shops
Jamaica
UnscheduledPsilocybin mushrooms never prohibited
Brazil
Religious UseAyahuasca legal for religious ceremonies
Canada
Medical AccessSection 56 exemptions for therapy
Portugal
DecriminalizedAll drugs decriminalized since 2001
Australia
Medical 2023First country to reschedule for therapy
✊ Reform Movements
Organizations and initiatives driving change
🔬 MAPS
Leading clinical trials for MDMA-assisted therapy for PTSD, pursuing FDA approval.
🍄 Decriminalize Nature
Grassroots movement working to decriminalize entheogenic plants and fungi in US cities.
💊 Drug Policy Alliance
Advocating for drug policy reform based on science, compassion, and human rights.
🧪 Heffter Research Institute
Funding psilocybin research at major universities to build scientific evidence base.
👤 Political Key Figures
People shaping psychedelic policy
Rick Doblin
Leading FDA approval efforts for MDMA therapy since 1986.
Rep. Alexandria Ocasio-Cortez
Championed amendments to allow psychedelic research funding.
Roland Griffiths
Pioneering researcher whose work influenced policy discussions.
Kevin Matthews
Led successful campaign to decriminalize psilocybin in Denver.
🔮 Future Outlook
What's next for psychedelic policy
💊 FDA Approval
MDMA and psilocybin may receive FDA approval for specific therapeutic uses in coming years.
🏛️ State Expansion
More states expected to consider legislation following Oregon and Colorado models.
🌍 International Reform
Growing momentum for reform in Canada, UK, and EU as research evidence mounts.
📊 Rescheduling Debate
Pressure building to reconsider Schedule I classification as medical benefits proven.
⭐ Your Saved Topics
Click on items to save them for reference